Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
about
The transcription factor p53: not a repressor, solely an activatorMutant p53 and ETS2, a Tale of ReciprocityThe Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic TargetOverrepresentation of transcription factor families in the genesets underlying breast cancer subtypesp53-independent roles of MDM2 in NF-κB signaling: implications for cancer therapy, wound healing, and autoimmune diseasesEts1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cellsAn IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity.A novel mechanism of crosstalk between the p53 and NFκB pathways: MDM2 binds and inhibits p65RelA.Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB.p53 Represses transcription of RING finger LIM domain-binding protein RLIM through Sp1Inflammation and p53: A Tale of Two StressesMutant p53 cooperates with ETS2 to promote etoposide resistance.Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.NF-kappaB activation in melanoma.Interactions of mutant p53 with DNA: guilt by association.Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growthRelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.Current position of TNF-α in melanomagenesis.NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.Increase in IkappaB kinase alpha expression suppresses the tumor progression and improves the prognosis for nasopharyngeal carcinoma.Protein microarray analysis of apoptosis-related protein expression following heat shock in human tongue squamous cell carcinomas containing different p53 phenotypes.Combination of proteasomal inhibitors lactacystin and MG132 induced synergistic apoptosis in prostate cancer cells.HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation.Over-expression of ΔNp63α facilitates rat corneal wound healing in vivo.ETS1 and SP1 drive DHX15 expression in acute lymphoblastic leukaemia.ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231.
P2860
Q24273295-2666DBD9-95B8-4D8C-8D57-9E40C52FFAC8Q26765746-D2E1BCD2-FD44-46AD-B323-1A872680A2BFQ28071415-28DC2807-FC8E-478E-8747-6671857D4E9FQ28388563-5CC6E9D2-C091-438B-834D-B840D351EB54Q28611425-5531361B-D77B-4758-BA87-2E3375308FDDQ33399714-FEBEAE5E-52EF-4D7B-B075-14DEBE22559AQ34155015-7B586EC8-8C4C-4D5A-BF8E-EDA4FE1B1C66Q34356362-4919318C-67DD-46D1-8025-4CABE2B5132BQ34540087-4103BF38-EC7A-429A-AD76-4C246204E8ADQ34708448-F78A217E-7328-490B-8668-710D553609A5Q35103171-0E9F9AAA-3D28-4E76-BEA9-40F198E080E2Q35914917-37BEA684-33E4-45DC-8C73-8A5DC0AC1503Q36414139-A392329B-AB8B-42CA-BB4C-45CB003674CFQ36416479-052A4FE2-4D5A-417E-A764-1B7228341FF5Q36777338-C1FB460E-A610-4BDD-AEF5-BCD98DA733CCQ37149856-7FC4F22A-DBD9-45C3-AE60-50C6E1353CB7Q37610194-749473F1-1A4B-4348-A7E0-3AEC7500FE33Q38567932-63B8D90B-ABB0-4C76-937A-A090B6558F22Q38915272-8980AF32-4C0D-4256-B688-A77243994868Q39002181-5EB99CA9-F728-46B1-AA1A-00CC8A35F152Q39907667-6805F5E8-7178-41E8-9FF9-85C317A2C9CEQ41472341-E740CD85-30C6-423F-A850-104C226CC6D6Q42314587-460E5780-AC80-4C90-A1A2-13CD5AA6E31AQ47579349-4DB7AA7C-E5DC-4171-9FD1-5AC481D8EDEDQ54233860-E40145C4-6086-404C-BF0D-99AC31D39675Q55315341-5F2CA231-E761-4DC7-B1A5-4106EF2CAE5A
P2860
Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Identification and characteriz ...... y ETS-1 and p53, respectively.
@en
type
label
Identification and characteriz ...... y ETS-1 and p53, respectively.
@en
prefLabel
Identification and characteriz ...... y ETS-1 and p53, respectively.
@en
P2093
P2860
P356
P1476
Identification and characteriz ...... y ETS-1 and p53, respectively.
@en
P2093
Harry W Findley
Muxiang Zhou
Ningxi Zhu
William G Woods
P2860
P304
52141-52149
P356
10.1074/JBC.M407915200
P407
P577
2004-10-05T00:00:00Z